Earnings Call · Q4 FY2023·2023-05-25

Q4 23EPS +1.29%·Rev n/aQ3 23EPS +2.36%·Rev n/aQ2 23EPS +1.56%·Rev n/aQ1 23EPS +0.89%·Rev n/a⚠ consensus missing

Medtronic plc MDT

Ryan Weispfenning — Vice President and Head of Investor Relations

Geoffrey Martha — Chairman and Chief Executive Officer

Karen Parkhill — Executive Vice President and Chief Financial Officer

−4.5%1d on move date−5.4% vs SPY3d−5.7%5d−5.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MDT calls or request research access.

More MDT calls Browse calls Request research access